[Treatment and prognosis of intrathoracic Hodgkin's disease (author's transl)].
Of 220 patients with Hodgkin's disease 117 (53%) who also had mediastinal and hilar lymph-node involvement were followed between 1958 and 1971. In 13 (11%) intrathoracic involvement was the first manifestation of the tumour. In 73 patients it was in stage I or II (Rye) at time of diagnosis. Treatment consisted of irradiation and/or multiple chemotherapy. Altogether 45% survived five years and 27% ten years. However, there was no patient who was free of recurrence after ten years, i.e. none can be considered as potentially cured.
D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000368:Aged; D002648:Child; D002675:Child, Preschool; D004359:Drug Therapy, Combination; D005260:Female; D006689:Hodgkin Disease / Q000175:diagnosis / Q000188:drug therapy / Q000532:radiotherapy / Q000628:therapy*; D006801:Humans; D007223:Infant; D008297:Male; D008482:Mediastinum; D008875:Middle Aged; D011379:Prognosis; D012008:Recurrence; D012737:Sex Factors; D013899:Thoracic Neoplasms / Q000175:diagnosis / Q000188:drug therapy / Q000532:radiotherapy / Q000628:therapy*; D013997:Time Factors
Therapie und Prognose bei intrathorakalem Morbus Hodgkin